Detoxification and endothelialization of glutaraldehyde-fixed bovine pericardium with titanium coating a new technology for cardiovascular tissue engineering

Circulation

Volumn 119, Issue 12, 2009, Pages 1653-1660

  Guldner, Norbert W ^a   Jasmund, Inka ^a   Zimmermann, Hanngörg ^b   Heinlein, Markus ^b   Girndt, Britta ^b   Meier, Veronika ^a   Flüß, Florian ^a   Rohde, Daniel ^c   Gebert, Andreas ^d   Sievers, Hans Hinrich ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Gesellschaft für Elektrometallurgie Medizintechnik GmbH   (Germany)

^c LÜBECK UNIVERSITY OF APPLIED SCIENCES   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Collagen; Endothelium; Surgery; Valves; Vessels

Indexed keywords

ALDEHYDE DEHYDROGENASE; CITRIC ACID; GLUTARALDEHYDE; TITANIUM; BIOMATERIAL; FIXATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CELL ADHESION; CELL VIABILITY; CHEMICAL PROCEDURES; CONTROLLED STUDY; COW; DETOXIFICATION; ENDOTHELIUM CELL; FLOW RATE; HEART VALVE PROSTHESIS; IN VITRO STUDY; LOW TEMPERATURE; MATERIAL COATING; NONHUMAN; PERICARDIUM; PHOTOMETRY; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCANNING ELECTRON MICROSCOPY; SHEAR STRESS; TISSUE ENGINEERING; ANIMAL; BIOPROSTHESIS; CATTLE; CELL SURVIVAL; CULTURE TECHNIQUE; CYTOLOGY; HUMAN; METHODOLOGY;

ALDEHYDE DEHYDROGENASE; ANIMALS; BIOPROSTHESIS; CATTLE; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CITRIC ACID; COATED MATERIALS, BIOCOMPATIBLE; ENDOTHELIAL CELLS; FIXATIVES; GLUTARAL; HEART VALVE PROSTHESIS; HUMANS; PERICARDIUM; PLASMA; TISSUE ENGINEERING; TITANIUM;

EID: 65249137023     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.823948     Document Type: Article

References (31)

1. Gudbjartsson TA, Cohn LH. Mechanical/bioprosthetic mitral valve replacement. In: Cohn LH, Edmunds LH Jr, eds. Cardiac Surgery in the Adult. New York, NY: McGraw-Hill; 2003:51-986.
2. Chen W, Schoen FJ, Levy RJ. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation. 2006;14:318-332.
3. Vesely I. The evolution of bioprosthetic heart valve design and its impact on durability. Cardiovasc Pathol. 2003;12:277-286.
4. Jamieson WR, Burr LH, Munro AI, Miyagishima RT. Carpentier- Edwards standard porcine bioprosthesis: a 21-year experience. Ann Thorac Surg. 1998;6(suppl):66-72.
5. Simionescu DT. Prevention of calcification in bioprosthetic heart valves: challenges and perspectives. Expert Opin Biol Ther. 2004;4:1971-1985.
6. Bengtsson L, Radegran K, Haegerstrand A. In vitro endothelialization of commercially available heart valve bioprostheses with cultured adult human cells. Eur J Cardiothorac Surg. 1993;7:393-398.
7. Eberl T, Siedler S, Schumacher B, Zilla P, Schlaudraff K, Fasol R. Experimental in vitro endothelialization of cardiac valve leaflets. Ann Thorac Surg. 1992;53:487-492.
8. Fischlein T, Fasol R. In vitro endothelialization of bioprosthetic heart valves. J Heart Valve Dis. 1996;5:58-65.
9. Fu P, Lan H, Wang D, Guan H. Experimental study on modified treatment and endothelialization of bovine pericardial valves. J Tongji Med Univ. 1997;17:136-139.
10. Jansson K, Bengtssoon L, Swedenborg J, Haegerstrand A. In vitro endo- thelialization of bioprosthetic heart valves provides a cell monolayer with proliferative capacities and resistance to pulsatile flow. J Thorac Cardiovasc Surg. 2001;121:108-115.
11. FischleinT, LehnerG, Lante W, ReichartB. Endothelializationofcardiac valve bioprostheses. Int J ArtifOrgans. 1994;17:345-353.
12. Lehner G, Fischlein T, Baretton G, Murphy JG, Reichart B. Endotheli- alized biological heart valve prostheses in the non-human primate model. Eur J Cardiothorac Surg. 1997;11:498-504.
13. Gulbins H, Goldemund A, Anderson I, Haas U, Uhlig A, Meiser B, Reichart B. Preseeding with autologous fibroblasts improves endotheli- alization of glutaraldehyde-fixed porcine aortic valves. J Thorac Cardiovasc Surg. 2003;125:592-601.
14. Gulbins H, Goldemund A, Uhlig A, Meisner B, Reichart B. Implantation of an autologously endothelialized homograft. J Thorac Cardiovasc Surg. 2003;126:890-891.
15. Gulbins H, Pritisanac A, Piper K. Successful endothelialization of porcine glutaraldehyde-fixed aortic valves in a heterotopic sheep model. Ann Thorac Surg. 2006;81:1472-1479.
16. Sivaram S. Chemical Vapor Deposition: Thermal and Plasma Deposition ofElectronic Materials. New York, NY: Van Nostrand Reinhold; 1995.
17. Grill A. Cold Plasma in Materials Fabrication: From Fundamentals to Applications. New York, NY: IEEE Press; 1994.
18. Dag B, ed. Surface Characterization. Weinheim, Germany: Wiley-VCH; 1997.
19. Moulderm JF, Stickle WF. Handbook of X Ray Photoelectron Spec- troscopy. New York, NY: Physical Electronics; 1995.
20. Williams D. The golden anniversary of titanium biomaterials. Med Device Technol. 2001;12:8-11.
21. Brunette DM. Titanium in Medicine. Berlin, Germany: Springer; 2001.
22. Sedelnikov N, Cikirikicioglu M, Osorio-Da Cruz S, Khabiri E, Donmez Antal A, Tille JC, Karaca S, Hess OM, Kalangos A, WalpothB. Titanium coating improves neo-endothelialisation of ePTFE grafts. Thorac Cardiovasc Surg. 2006;54(suppl 1):83-115.
23. Guldner N, Jasmund I, Zimmermann H, Heinlein M, Girndt B, GroBherr M, Klinger A, Sievers HH. The first self-endothelialized titanium coated glutaraldehyde-fixed heart valve prosthesis within systemic circulation. Thorac Cardiovasc Surgery. In press. DOI: 10.1016/j.jtcvs.2008.11.045.
24. Kockerling F, Scheidbach P, Tannapfel A, Schmidt U, Lippert H. Influence of titanium coating on the biocompatibility of a heavyweight polypropylene mesh. Eur Surg Res. 2004;36:313-317.
25. Schug-PaB C, Tamme C, Tannapfel A, Kockerling F. A lightweight polypropylene mesh (TiMesh) for laparoscopic intraperitoneal repair of abdominal wall hernias: comparison of biocompatibility with the DualMesh in an experimental study using the porcine model. Surg Endosc. 2006;20:402-409.
26. Durnev AD. Toxicology of nanoparticles. Bull Exp Biol Med. 2008;145: 72-74.
27. Carrel TP, Schoenhoff FS, Schmidli J, Stalder M, Eckstein FS, Engel- berger L. Deleterious outcome of No-React-treated stentless valved conduits after aortic root replacement: why were warnings ignored? J Thorac Cardiovasc Surg. 2008;136:52-57.
28. Carrel TP. Another disastrous outcome following aortic replacement with the Shelhigh No-React aortic valved tube. Thorac Cardiovasc Surg. 2008;56:314-315.
29. Ishizaka T, Ohye RG, Goldberg CS, Ramsburg SR, SusukiT, Devaney EJ, Bove EL. Premature failure of a small-sized Shelhigh No-React porcine pulmonic valve conduit model NR-4000. Eur J Cardiothorac Surg. 2003; 23:715-718.
30. Boudjemline Y, Beyler C, Bonnet D, Didi D. Surprising outcome similarities between Contegra® bovine jugular vein conduit and Shelhigh No-React1. Gudbjartsson TA, Cohn LH. Mechanical/bioprosthetic mitral valve replacement. In: Cohn LH, Edmunds LH Jr, eds. Cardiac Surgery in the Adult. New York, NY: McGraw-Hill; 2003:51-986.
31. Sievers HH. In vivo tissue engineering an autologous semilunar biovalve: can we get what we want? Thorac Cardiovasc Surg. 2007;134:20-22.